2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, IPCE Part 1: Up to 70% of people with MS suffer from cognitive dysfunction, which can have a profound impact on everyday life. Treatment can include cognitive rehabilitation, exercise and medication. This symposium will provide an evidence-based perspective on treatment approaches …
Accreditation Archives:
Whitaker Invited Lectures
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE This session will explore emerging and high-impact developments shaping the future of multiple sclerosis (MS) care and research. Dr. Moein Amin will discuss the expanding role of artificial intelligence in MS, highlighting applications in diagnosis, imaging analysis, prognostication, and …
Beyond the Label: Navigating Biomarkers, Supplements, and High-Risk Patients
2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE This course will provide practical insights into clinical management strategies of multiple sclerosis. The presentations will focus on clinical implementation of biomarkers, management of high-risk patients and provide perspectives on supplements and MS care. Multiple sclerosis (MS) remains a clinically heterogeneous disease with …
Continue reading “Beyond the Label: Navigating Biomarkers, Supplements, and High-Risk Patients”
Stronger You, Stronger MS Care
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE Delivering exceptional MS care requires purpose driven, adaptable, and engaged teams. This interactive course explores how workforce wellbeing can be integrated into leadership and professional development. Using evidence-based frameworks and practical tools, participants will learn strategies to foster meaning …
Fundamentals of MS Care Part 3 Matching Treatment Decisions for the Disease Course, Co-Morbidities, Caring for Men with MS and Aging and Disability in MS: Navigating Progression
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE SESSION III of Fundamentals offers a Multidisciplinary approach in the management of multiple sclerosis (MS). Presentations will include an overview of matching disease modifying therapies (DMT) to the individual’s disease course, challenges in the treatment of MS with co-Morbidities, …
Managing Non-Multiple Sclerosis Patients in a Multiple Sclerosis Practice: Rare Neuroimmunological Disorders – Everything You Need to Know Part 3
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE This session will introduce participants to the biologic and clinical basics of rare neuroimmune conditions such as neuromyelitis optic, anti-MOG associated disorder, autoimmune encephalitis, myelitis, neurosarcoidosis and stiff person syndrome. Participants will be educated about diagnostic criteria and appropriate …
Advances in CSF Biomarkers for Multiple Sclerosis
2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE The brain’s ‘soup’ or CSF is rich with information that may exude from processes within the CNS. It is once again an integral part of the new diagnostic criteria, but an alternative assay to the usual and tedious detection of CSF-specific IgG oligoclonal …
Continue reading “Advances in CSF Biomarkers for Multiple Sclerosis”
MS in Underserved Populations: Understanding Needs and Improving Outcomes
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE Multiple sclerosis outcomes are influenced by far more than disease biology alone. Social determinants of health—including access to care, insurance coverage, transportation, employment, education, social support, and health system design—play a critical role in shaping when MS is diagnosed, …
Continue reading “MS in Underserved Populations: Understanding Needs and Improving Outcomes”
Whitaker Platform Session
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE This platform session will feature cutting-edge investigations from emerging and established researchers, highlighting novel insights into the biological mechanisms, biomarkers, and clinical manifestations of multiple sclerosis (MS). Presentations will explore accelerated aging in MS through neuroimaging and proteomic approaches, …
Donald Paty Lecture: Adventures at the Poles: Ultra-Low and Ultra-High-Field MRI for MS
2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE In this talk, I will compare what MRI can and cannot show in multiple sclerosis at the two ends of the field-strength spectrum: portable ultra-low-field (e.g., 64 millitesla) and ultra-high-field (e.g., 7 tesla). I will discuss how field strength changes image quality and …